Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials

Advances in our understanding of cystic fibrosis pathogenesis have led to strategies directed toward treatment of underlying causes of the disease rather than treatments of disease-related symptoms. To expedite evaluation of these emerging therapies, early-phase clinical trials require extension of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rowe, Steven M., Accurso, Frank, Clancy, John P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Thoracic Society 2007
Témata:
Symposium: Measures for Development of New Therapies in Cystic Fibrosis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2647604/
https://ncbi.nlm.nih.gov/pubmed/17652506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/pats.200703-043BR
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky